The Penguin recently aired its sixth episode. The episode was filled with interesting twists and turns, leaving viewers on ...

The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes in people with dementia with ...

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Symptoms can ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

Lewy Body Dementia is a type of dementia caused by the build-up of proteins called Lewy bodies in the brain. These proteins damage parts of the brain responsible for thinking, movement and memory.

Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...

CervoMed (CRVO) will deliver an oral presentation providing detailed safety and efficacy results from its completed RewinD-LB Phase 2b clinical ...

Other causes may include vascular dementia, Lewy body dementia, brain injuries, and certain underlying health conditions. Major neurocognitive disorder, also known as dementia, is a ...

“The evidence would suggest that perhaps we need to investigate this pathway and perhaps this drug in both Parkinson’s, ...

Lewy body dementia is a progressive neurodegenerative disease that shares traits with both Parkinson’s and Alzheimer’s diseases but can be more difficult to diagnose. Symptoms can include ...